The hedge fund’s shares of CHS are valued at $2.17 million. CHS makes up about 0.35 percent of Rhenman’s portfolio, according to Trade Calls.
Other hedge funds, including Tradelink Capital and Deltec Asset Management, also lowered their stakes in CHS in the most recent quarter.
More articles on healthcare finance:
Indiana woman held by Cancún hospital for $53k bill
8 recent hospital outlook and credit rating actions
Mizuho: Some healthcare companies adjust earnings too much
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
